ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,066Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 761

$577K Total Retail Price of All Prescriptions

Rank: 79 out of 761

464 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

17% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,748 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
OMEPRAZOLE 391 332 1 4
LISINOPRIL 364 301 2 1
HYDROCODONE-ACETAMINOPHEN 341 208 S3 3 5
SIMVASTATIN 312 308 4 2
PRAVASTATIN SODIUM 291 235 5 20
LEVOTHYROXINE SODIUM 287 230 6 3
GABAPENTIN 284 209 7 15
FUROSEMIDE 281 250 8 7
AMLODIPINE BESYLATE 227 176 9 6
ATENOLOL 221 178 10 8
ATORVASTATIN CALCIUM 219 184 11 12
TRAZODONE HCL 212 167 12 23
WARFARIN SODIUM 190 170 13 9
METFORMIN HCL 179 112 14 10
METOPROLOL TARTRATE 163 147 15 14
CITALOPRAM HBR 154 151 16 19
HYDROCHLOROTHIAZIDE 142 122 17 11
SPIRIVA 141 118 18 56
METOPROLOL SUCCINATE 138 124 19 16
SERTRALINE HCL 132 111 20 25
POLYETHYLENE GLYCOL 3350 128 74 21 62
FAMOTIDINE 120 95 22 60
LOVASTATIN 119 108 23 17
PANTOPRAZOLE SODIUM 116 101 24 40
LANTUS 114 95 25 41
POTASSIUM CHLORIDE 112 102 26 18
FLUTICASONE PROPIONATE 104 68 27 29
ENALAPRIL MALEATE 100 82 28 71
LOSARTAN POTASSIUM 97 87 29 13
ADVAIR DISKUS 91 76 30 37
LIDODERM 89 59 31 163
PAROXETINE HCL 86 86 32 47
CRESTOR 86 81 32 36
DIGOXIN 80 80 34 43
PROAIR HFA 79 56 35 32
CARVEDILOL 77 68 36 26
HUMALOG 75 69 37 123
OXYCODONE HCL 75 54 S2 37 24
NOVOLOG 72 54 39 129
NAMENDA 71 71 40 59
VENLAFAXINE HCL ER 71 63 40 76
TIZANIDINE HCL 69 17 42 139
AMITRIPTYLINE HCL 69 46 R 42 54
GLIPIZIDE 65 56 44 39
ACTONEL 65 65 44 171
FLUOXETINE HCL 63 21 46 31
GLIMEPIRIDE 61 52 47 48
AMOXICILLIN 61 43 47 200
AGGRENOX 60 55 49 121
BUSPIRONE HCL 60 36 49 154
AZITHROMYCIN 59 41 51 70
TRIAMTERENE-HCTZ 57 42 52 42
OXYCODONE-ACETAMINOPHEN 54 29 S2 53 49
SINGULAIR 53 32 54 138
ALLOPURINOL 52 49 55 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 51 56 35
ALENDRONATE SODIUM 51 51 56 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.